Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROXYUREA Cause Second primary malignancy? 46 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Second primary malignancy have been filed in association with HYDROXYUREA (Hydroxyurea). This represents 0.8% of all adverse event reports for HYDROXYUREA.

46
Reports of Second primary malignancy with HYDROXYUREA
0.8%
of all HYDROXYUREA reports
12
Deaths
14
Hospitalizations

How Dangerous Is Second primary malignancy From HYDROXYUREA?

Of the 46 reports, 12 (26.1%) resulted in death, 14 (30.4%) required hospitalization.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROXYUREA. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROXYUREA Cause?

Off label use (519) Anaemia (358) Drug ineffective (356) Fatigue (291) Thrombocytopenia (253) Nausea (247) Pyrexia (243) Diarrhoea (222) Febrile neutropenia (202) Intentional product use issue (201)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which HYDROXYUREA Alternatives Have Lower Second primary malignancy Risk?

HYDROXYUREA vs HYDROXYZINE HYDROXYUREA vs HYDROXYZINE\HYDROXYZINE HYDROXYUREA vs HYOSCYAMINE HYDROXYUREA vs HYPROMELLOSE 2910 HYDROXYUREA vs IBALIZUMAB-UIYK

Related Pages

HYDROXYUREA Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy HYDROXYUREA Demographics